Department of Orthodontic, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran.
General Dentistry, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Lasers Med Sci. 2024 Sep 25;39(1):239. doi: 10.1007/s10103-024-04186-w.
This study compared the efficacy of pharmaceutical (ibuprofen) and non-pharmaceutical (photobiomodulation and chewing gum) interventions for pain reduction after elastomeric separator placement in orthodontic patients. This 3-arm, parallel-group randomized clinical trial was conducted on 90 orthodontic patients. The level of anxiety and pain threshold of patients were measured at baseline using the Pain Catastrophizing Scale (PCS) and an algometer, respectively. The patients were randomly assigned to three groups (n = 30; equal number of males and females). In the laser group, 940 nm diode laser (Epic X, Biolase, USA, 12.35 J/cm2 energy density and 300 mW power in continuous-wave mode., The cross-sectional area of the laser handpiece tip was 1.7 cm2.) was irradiated to the buccal and lingual surfaces for 35 s each, prior to placement of separators. In the gum group, the patients were asked to chew a piece of sugar-free gum immediately after the placement of separators and repeat every 8 h for 5 min for one week in case of pain. In the ibuprofen group, patients received 400 mg ibuprofen (Hakim Pharmaceuticals, Tehran, Iran) after the placement of separators and were asked to take one tablet every 8 h for one week in case of pain. The pain score was recorded using the Modified McGill Pain Questionnaire (MPQ). The normality of data distribution was analyzed by the Kolmogorov-Smirnov test. ANOVA was applied to compare age, and the Chi-square and Monte Carlo Chi-square tests were used to compare gender and patient responses to the questions among the groups. Repeated measures ANOVA was used to compare the pain score at different time points and among the three groups. All statistical analyses were conducted using SPSS version 19 (SPSS Inc., Chicago, IL, USA) at 0.05 level of significance. Data analysis in this study had an intention to treat approach. Although the pain score was slightly lower in ibuprofen and gum groups, the difference among the three groups was not statistically significant (P > 0.05). 'Repeated measures ANOVA showed no significant effect of method of pain reduction on pain score (F = 1.520, P = 0.225). Time had a significant effect on pain score (F = 20.310, P < 0.001). The interaction effect of time and pain reduction method on pain score was not significant (F = 0.737, P = 0.651). patients experienced a lower level of pain in the ibuprofen and chewing gum groups, the difference in pain score was not significant among the three groups (P = 0.225). patients experienced a higher level of pain at 12 and 24 hours after the placement of separators in all groups. Considering the comparably equal analgesic efficacy of this modalities, non-pharmaceutical interventions can be used for pain reduction of elastomeric separator. The study protocol was registered in the Iranian Registry of Clinical Trials (IRCT20210927052611N1). Date of registration 2022/03/14.
本研究比较了药物(布洛芬)和非药物(光生物调节和咀嚼口香糖)干预措施在正畸患者放置弹性分离器后减轻疼痛的效果。这是一项三臂、平行组随机临床试验,纳入了 90 名正畸患者。使用疼痛灾难化量表(PCS)和压痛计分别在基线时测量患者的焦虑水平和疼痛阈值。患者被随机分配到三组(每组 30 人;男女比例相等)。在激光组中,使用 940nm 二极管激光(美国 Biolase 的 Epic X,能量密度为 12.35J/cm2,连续波模式下功率为 300mW。激光手柄尖端的横截面积为 1.7cm2)照射颊侧和舌侧各 35s,然后放置分离器。在口香糖组中,患者在放置分离器后立即咀嚼一块无糖口香糖,如果疼痛,每 8 小时重复咀嚼 5 分钟,持续一周。在布洛芬组中,患者在放置分离器后服用 400mg 布洛芬(伊朗 Hakim 制药公司),如果疼痛,每 8 小时服用一片,持续一周。使用改良麦吉尔疼痛问卷(MPQ)记录疼痛评分。通过 Kolmogorov-Smirnov 检验分析数据分布的正态性。使用 ANOVA 比较年龄,使用卡方检验和 Monte Carlo 卡方检验比较组间性别和患者对问题的反应。使用重复测量 ANOVA 比较不同时间点和三组之间的疼痛评分。所有统计分析均使用 SPSS 版本 19(芝加哥 IL 的 SPSS Inc.)在 0.05 水平进行。本研究的数据分析采用意向治疗方法。虽然布洛芬组和口香糖组的疼痛评分略低,但三组间差异无统计学意义(P>0.05)。重复测量 ANOVA 显示,减轻疼痛的方法对疼痛评分无显著影响(F=1.520,P=0.225)。时间对疼痛评分有显著影响(F=20.310,P<0.001)。时间和减轻疼痛方法对疼痛评分的交互作用不显著(F=0.737,P=0.651)。虽然患者在布洛芬组和口香糖组中疼痛程度较低,但三组间疼痛评分差异无统计学意义(P=0.225)。所有组的患者在放置分离器后 12 和 24 小时疼痛程度较高。考虑到这些方法的镇痛效果相当,非药物干预可用于减轻弹性分离器引起的疼痛。研究方案已在伊朗临床试验注册中心(IRCT20210927052611N1)注册。注册日期 2022 年 3 月 14 日。